DOUBLE BLIND [resa]
Comparison [acty]
Estrogen [horm, phsu, strd]
Androgen [horm, phsu]
Conjugated [spco]
Estrogens [horm, phsu, strd]
Surgically [hlca]
Menopausal [phsf]
Women [popg]
effects [qlco]
Bone [bpoc]
Mineral [inch]
density [qnco]
symptoms [ftcn]
Lipid [lipd]
Profile [lbpr]
Objective [inpr]
effects [qlco]
Doses [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Esterified estrogen [horm, phsu, strd]
Pill [phsu]
Methyltestosterone [horm, phsu, strd]
Ill [sosy]
Surgically [hlca]
Menopausal [phsf]
Women [popg]
Study Design [resa]
Parallel [qlco]
Group [idcn]
Double-Blind Study [resa]
Women [popg]
Assigned [ftcn]
regimens [inpr]
mg/d [qnco]
mg/d [qnco]
Estrogens, Esterified [horm, phsu, strd]
mg% [qnco]
Methyltestosterone [horm, phsu, strd]
mg/d [qnco]
Estrogens, Esterified [horm, phsu, strd]
Methyltestosterone [horm, phsu, strd]
2 5 [qnco]
mg/d [qnco]
Study [mnob]
Parameters [fndg]
symptoms [ftcn]
Lipids [lipd]
Bone Mineral Density [clna]
side effects [ftcn]
Safety [hcpp]
Treatments [topp]
PREVENT [phsu]
Loss [qnco]
Bone [bpoc]
Ill [sosy]
Spine [bpoc]
Hip [bpoc]
High dose [qnco]
Increased [qnco]
Spine [bpoc]
Hip [bpoc]
BMD [clna]
Treatments [topp]
P NOS [aapp, imft]
Treatments [topp]
Improved [qlco]
menopausal symptoms [sosy]
Improvement [cnce]
Veil [mnob]
Sexual interest [fndg]
Group [idcn]
decreases [qnco]
Low density lipoprotein [aapp, bacs, lipd]
Observed [ftcn]
Group [idcn]
High density lipoprotein [aapp, bacs, lipd]
Triglycerides [bacs, lipd]
Increased [qnco]
Estrogen [horm, phsu, strd]
Group [idcn]
P NOS [aapp, imft]
Hirsutism [fndg]
Uncommon [qlco]
Group [idcn]
Discontinuation [hlca]
Reason [idcn]
Withdrawal [acty]
Study [mnob]
Group [idcn]
side effects [ftcn]
LABORATORY ABNORMALITIES [lbtr]
Test [lbpr]
Seen [qlco]
Compared [acty]
Estrogen [horm, phsu, strd]
Alone [qnco]
Improved [qlco]
BMD [clna]
Well [qlco]
Surgically [hlca]
Menopausal [phsf]
Women [popg]
